PRVA — Privia Health Cashflow Statement
0.000.00%
- $2.81bn
- $2.37bn
- $1.74bn
- 80
- 30
- 80
- 68
Annual cashflow statement for Privia Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 30.9 | -191 | -12.1 | 21 | 17 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.618 | 254 | 68 | 37.1 | 56.7 |
Other Non-Cash Items | |||||
Changes in Working Capital | 13.4 | 18 | -6.35 | 8.66 | 19.5 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 38.9 | 55.1 | 47.2 | 80.8 | 109 |
Capital Expenditures | -0.38 | -0.547 | -0.104 | -0.113 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | -32.2 | 0 | -42.9 | -12 |
Acquisition of Business | |||||
Sale of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.38 | -32.8 | -0.104 | -43 | -12 |
Financing Cash Flow Items | 0 | -13 | 0.125 | -5.04 | 1.65 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.767 | 214 | -19.7 | 3.71 | 4.33 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 37.7 | 236 | 27.4 | 41.5 | 102 |